1. Home
  2. ICUI vs KTB Comparison

ICUI vs KTB Comparison

Compare ICUI & KTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • KTB
  • Stock Information
  • Founded
  • ICUI 1984
  • KTB 2018
  • Country
  • ICUI United States
  • KTB United States
  • Employees
  • ICUI N/A
  • KTB N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • KTB Apparel
  • Sector
  • ICUI Health Care
  • KTB Consumer Discretionary
  • Exchange
  • ICUI Nasdaq
  • KTB Nasdaq
  • Market Cap
  • ICUI 3.4B
  • KTB 3.6B
  • IPO Year
  • ICUI 1992
  • KTB N/A
  • Fundamental
  • Price
  • ICUI $133.44
  • KTB $68.38
  • Analyst Decision
  • ICUI Strong Buy
  • KTB Strong Buy
  • Analyst Count
  • ICUI 5
  • KTB 6
  • Target Price
  • ICUI $196.75
  • KTB $87.50
  • AVG Volume (30 Days)
  • ICUI 215.9K
  • KTB 652.8K
  • Earning Date
  • ICUI 08-06-2025
  • KTB 07-31-2025
  • Dividend Yield
  • ICUI N/A
  • KTB 2.95%
  • EPS Growth
  • ICUI N/A
  • KTB 3.07
  • EPS
  • ICUI N/A
  • KTB 4.07
  • Revenue
  • ICUI $2,420,093,000.00
  • KTB $2,599,277,000.00
  • Revenue This Year
  • ICUI N/A
  • KTB $18.27
  • Revenue Next Year
  • ICUI N/A
  • KTB $10.96
  • P/E Ratio
  • ICUI N/A
  • KTB $17.32
  • Revenue Growth
  • ICUI 7.22
  • KTB 1.08
  • 52 Week Low
  • ICUI $117.92
  • KTB $50.00
  • 52 Week High
  • ICUI $196.26
  • KTB $96.80
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 50.47
  • KTB 51.31
  • Support Level
  • ICUI $129.26
  • KTB $67.91
  • Resistance Level
  • ICUI $139.41
  • KTB $71.43
  • Average True Range (ATR)
  • ICUI 4.24
  • KTB 2.23
  • MACD
  • ICUI 0.53
  • KTB 0.35
  • Stochastic Oscillator
  • ICUI 59.68
  • KTB 56.73

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About KTB Kontoor Brands Inc.

Kontoor Brands Inc is a lifestyle apparel company. It is engaged in designing, manufacturing, sourcing, marketing, and distribution of its portfolio of brands, including Wrangler and Lee. It manufactures its products in owned and leased facilities and distributes the products through both brick-and-mortar and e-commerce retailers. The Company has two reportable segments: Wrangler and Lee. It generates the majority of its revenue from the Wrangler segment. The company's geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

Share on Social Networks: